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Abstract: The purpose of the study was to develop tumor specific, water dispersible 
  superparamagnetic iron oxide nanoparticles (SPIONs) and evaluate their efficacy as a con-
trast agent in magnetic resonance imaging (MRI). We have developed SPIONs capped with 
citric acid/2-bromo-2-methylpropionic acid which are compact, water dispersible, biocom-
patible having narrow range of size dispersity (8–10 nm), and relatively high T2 relaxivity 
(R2 = 222L ⋅ mmol−1 ⋅ sec−l). The targeting efficacy of unconjugated and folic acid-conjugated 
SPIONs (FA-SPIONS) was evaluated in a folic acid receptor overexpressing and negative tumor 
cell lines. Folic acid receptor-positive cells incubated with FA-SPIONs showed much higher 
intracellular iron content without any cytotoxicity. Ultrastructurally, SPIONs were seen as clus-
tered inside the various stages of endocytic pathways without damaging cellular organelles and 
possible mechanism for their entry is via receptor mediated endocytosis. In vitro MRI studies 
on tumor cells showed better T2-weighted images in FA-SPIONs. These findings indicate that 
FA-SPIONs possess high colloidal stability with excellent sensitivity of imaging and can be a 
useful MRI contrast agent for the detection of cancer.
Keywords: superparamagnetic iron oxide nanoparticles (SPION), cellular internalization, 
magnetic resonance imaging (MRI), cancer-cell targeting ligand
Introduction
Super paramagnetic iron oxide nanoparticles (SPIONs) have garnered increased atten-
tion for their role in biomedical applications such as targeted delivery, localized therapy, 
stem cell labeling, tracking, and as contrast agents for magnetic resonance imaging 
(MRI).1–3 Currently, a number of SPIONs are either in early stage clinical trials or in 
preclinical studies.1,4 Some examples are: Lumiren for bowel imaging,5 Feridex 4® 
for liver and spleen imaging,6 Combidex for lymph node metastases imaging,7 and 
most recently, Ferumoxytol for iron replacement therapy.8 The physicochemical 
profiles of these SPIONs provide passive targeting, but not the higher level targeting 
offered by bioligands. Attachment of bioactive molecules to the SPION surface can 
potentially increase the targeting specificity of nanoparticles,4,9,10 producing contrast 
agents that specifically illuminate targeted tissue and drug carriers that do not interact 
with healthy tissue.6,10
The co-precipitation method is widely used for the synthesis of iron oxide 
nanoparticles,11 but nanoparticles obtained by this method have a broad range of 
size distribution and are also not highly stable.12 Currently, significant work on the 
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development and characterization of SPIONs is underway. 
The creation of next generation SPIONs (Fe3O4 and γ-Fe2O3) 
can be obtained by thermal decomposition methods. These 
SPIONs can be used as molecular imaging probes due to 
their high crystallinity and monodispersity. However they 
are only soluble in organic solvents due to the hydrophobic 
alkyl ligands on their surface.9,13–15 Water solubility and 
surface functionality are the two critical parameters neces-
sary for interaction with biological systems. This includes 
surface coating or ligand exchange to make the SPIONs water 
  dispersible. These surface coatings directly affect the biologi-
cal activities of nanoparticles; in particular, cellular uptake,15 
bio-distribution,16 blood circulation,17 and metabolism.18 
Depending on the application, the efficacy of nanoparticles 
can be directly influenced by the surface coatings. All of these 
surface coatings, besides giving the SPIONs water solubility, 
also provide functional groups for the attachment of various 
ligands for targeted delivery or concentrating the resulting 
complexes to the desired locale. Targeting the SPION con-
trast agents to specifically accumulate in regions of interest 
greatly enhances their clinical utility.11,19,20 Other studies 
have demonstrated various approaches for active targeting of 
SPIONs including peptides, hormones, aptamers, antibodies, 
proteins, therapeutics, and nutrients. Antibodies are inher-
ently immunogenic and are also bulky; both properties are 
believed to inhibit internalization of attached structures.21 The 
nutrient pathways are attractive since they are directly linked 
to proliferation and thus in principle will cause increased 
uptake of the imaging agent and therefore give greater 
signals for most tumor types. The folic acid receptor (FAR) 
is overexpressed in a wide variety of human tumors, as folic 
acid (FA) is a key precursor in DNA base synthesis and is 
thus required for tumor cell proliferation.22–24
In the present study, we demonstrate that combining more 
than one ligand, as effective phase transfer agents for SPIONs 
to transfer them from the organic phase to the water phase, is 
crucial for their colloidal stability and clinical utility. These 
coatings act as stabilizers for the magnetite nanoparticles 
and also provide a functionality to attach biological moiety 
to target the particles to cells. Additionally, we have also 
studied the stability of water soluble FA-conjugated SPIONs. 
We have successfully demonstrated selective binding, effec-
tive uptake, and the kinetics of FA-conjugated SPIONs 
into various tumor cell lines. Furthermore, we have also 
demonstrated the magnetic resonance (MR) properties of 
FA-conjugated SPIONs. Our studies were directed towards 
increasing the concentration of SPIONs into tumor cells by 
conjugating SPIONs with a targeted ligand, folic acid (FA). 
Internalization kinetics studies were performed in detail to 
optimize the maximum uptake of SPIONs into the tumor 
cells. The main aim of the present study was to design 
SPIONs, which can be used as a potential candidate for 
specific and sensitive cancer diagnosis.
Materials and methods
Materials
Iron (3) chloride hexahydrate (FeCl3 ⋅ 6H2O), 1-octadecene 
(ODE), oleic acid (99.5%), folic acid, N-hydroxy   succinamide 
(NHS), 1-ethyl-3-(-3-diethylaminopropyl)-carbodiimide 
(EDC), Dulbecco’s Modified Eagle Medium (DMEM), 
fetal bovine serum (FBS), penicillin, and streptomycin were 
p  urchased from Sigma Aldrich (St Louis, MO). Sodium 
hydroxide, methanol (HPLC grade), toluene, potassium 
f  errocynide, DPX mount, and hydrochloric acid were 
  purchased from Qualigens Fine Chemical (Mumbai, India).
Methods
Synthesis of SPIONs
The nanoparticles were synthesized according to protocol 
by Jana et al25 ligand exchange of oleic coated SPION with 
tetramethyl ammonium hydroxide (TMAOH) was done 
according to protocol by Salgueirino-Maceira et al26 and 
dimercaptosuccinic acid (DMSA) was done according to 
Chen et al.27
Preparation of citric acid coated SPION
Ligand exchange of oleic coated SPION with citric acid 
was done according to the procedures given by Lattuda and 
Hatton28 with slight modification. Oleic acid coated nanopar-
ticles (120 mg) prepared as described above were dispersed 
in a 1:1 mixture of 1,2-dichlorobenzene and N,N-dimethyl 
formamide (30 mL of total volume), to which 0.1 g of 
citric acid was added. The mixture was then stirred at 90°C 
for ∼12 hours. The particles were subsequently precipitated 
by the addition of ethanol (40 mL) and separated using a 
magnet. The particles were redispersed in acetone and again 
separated by means of a magnet 3 to 4 times to remove all 
traces of free citric acid. The particles were then dried in a 
vacuum oven for 20 minutes at 80°C.
Preparation of citric acid/2-bromo-2-methylpropionic 
acid coated SPION (CA/BMPA-SPIONs)
The procedure used here is identical to that described in 
citric acid coating of magnetic nanoparticles,28 with slight 
modification, wherein a mixture of 0.050 g of citric acid and 
0.4 g of 2-bromo-2-methylpropionic acid was used for the 
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ligand exchange reaction. Bio conjugation of CA/BMPA 
coated SPION with folic acid was done using the same 
procedures as You et al.29
Prussian blue staining
To demonstrate Fe in the target cells (MCF-7, HepG2, 
A549), 5 × 104 cells were seeded on coverslips in twelve well 
culture plates and grown for 24 hours. Then the cells were 
incubated with FA-SPION and non-conjugated SPIONs with 
different concentrations of SPION (25–200 µg/mL). After 
incubation of 6 hours, the coverslips were removed followed 
by washing with phosphate buffer saline (PBS) solution and 
finally fixed with 4% paraformaldehyde for 20 minutes at 
room temperature. After removing the fixing agent, the cells 
were washed and stained with Prussian blue iron stain. The 
SPIONs were labeled and the control cells were incubated 
with a 1:1 mixture of 4% potassium ferrocyanide and 4% 
hydrochloric acid for 20 minutes, and washed with distilled 
water several times. To stain the nuclei the cells were treated 
with nuclear fast red solution (Polysciences, Inc, Warrington, 
PA) for 5 minutes and then rinsed in running tap water for 
1 minute. After drying the cells, a cover slip was mounted by 
using a mounting medium (Dako, Carpenteria, CA) and then 
the cells were observed using light microscopy (Olympus, 
Fluoview FV1000 Microscope, Japan).
Transmission electron microscopy (TEM) study
MCF-7 cells were grown in twelve well cell culture plates. 
After 48 hours FA-SPION (100 µg/mL) were added and incu-
bated for different time intervals (1, 3, and 6 hours) and the 
rest of the procedure was performed according to Zhou et al.30 
Finally, samples were viewed under an electron microscope 
(Morgagni 268; Philips, Amsterdam, Netherlands).
XTT assay
A cytotoxicity test of the SPIONs was performed according 
to the manufacturer’s protocol (Cayman Chemical Com-
pany, Ann Arbor, MI) as follows. A total of 5 × 104 cells 
were seeded on each well of a 96-well plate and cultured for 
24 hours. The cells were treated with different concentra-
tions of SPION’s (62.5, 125, 250, 500, and 1000 µg Fe/mL) 
in a serum-free medium for 24 hours and 48 hours. After 
incubation, the medium containing SPION’s was exchanged 
with a fresh medium, and 10 µL of the reconstitute XTT 
mixture kit reagent were added to each well. After cultur-
ing for 4 hours, the absorbance of the sample was measured 
by using a microtiter plate reader (Bio-Rad, Hercules, CA) 
at 450 nm. The viability of the cells was determined as 
the percentage of viable cells of the untreated control and 
  analyzed in triplicate.
Cellular uptake study
To study the intracellular uptake of surface-modified nano-
particles, 1 × 105 cells were initially plated and grown to 
60% confluence in twelve well culture plates. Cells were then 
washed twice with PBS and cultured in 10 mL of DMEM 
containing 10% FBS and 1% penicillin/streptomycin for 
24 hours. The growth medium was then aspirated and the cells 
were washed twice with PBS. The effect of surface coating 
on the uptake of nanoparticles by MCF-7 and HepG2 cells 
was evaluated by culturing these cells with FA-SPION and 
unconjugated SPION, each dispersed in DMEM at a con-
centration range of 10–400 µg Fe/mL for 6 hours. While 
in time-dependent study, cells were incubated with a fixed 
concentration of 100 µg Fe/mL for different time intervals 
ranging from 0.5 to 12 hours. A plate of control cells was pre-
pared in a similar manner without the addition of nanoparticles. 
At the end of incubation, cells were washed three times with 
PBS, detached with trypsin-EDTA, and resuspended in 1 mL of 
PBS containing 5% FBS. Cell concentrations were determined 
by hemocytometer using trypan blue dye. The specific uptake 
of FA-SPION conjugates by MCF-7 and HepG2 cells was 
  further examined in a competitive uptake inhibition assay, where 
FA-SPION was incubated with 10 mM of free folic acid. To 
evaluate the specificity of cellular targeting of the nanoparticle 
conjugates, the uptake of FA-SPION conjugates by MCF-7 
and HepG2 cells was compared with the uptake by A549 cells 
that do not overexpress the folate receptor. A549 cells were 
cultured with different concentrations (10 to 400 µg Fe/mL) and 
for different time periods (0.5–12 hours) with FA-SPION and 
unconjugated SPION in a similar manner as with the MCF-7 
and HepG2 cells. The cells were then detached and counted as 
mentioned above. Intracellular uptake of the nanoparticles was 
quantified by atomic absorption spectroscopy (AAS), where a 
known number of cells from each sample were analyzed for 
iron content. AAS samples were prepared by centrifuging down 
the cells and dissolving the cell pellet in 37% hydrochloric 
acid at 70°C for 3 hours. The samples were then diluted to a 
volume of 3 mL for analysis. Intracellular uptake experiments 
were performed in triplicate with percent error determined by 
calculating the standard deviation of these measurements.
Magnetic resonance imaging
Preparation of phantom agar gels for imaging
Suspensions of FA-SPION in the concentration range of 
0–20 µg/mL of Fe were prepared in PBS. A 2.0% w/v agar 
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solution was prepared by heating 200 mg of agar in 10 mL 
of PBS at 80°C for 20 minutes. For preparing phantom gels, 
160 µL of the above agar solution was mixed thoroughly with 
vigorous shaking with 840 µL of SPION suspension at each 
concentration at 60°C to prevent gelation while mixing and 
poured in 1.5 mL microcentrifuge tubes, followed by the 
cooling of the these tubes at room temperature.
A total of 5 × 104 cells were seeded on each well of a 
twelve-well plate and grown for 24 hours. The cells were 
then incubated with a medium containing different concen-
trations (40–160 µg/mL) of FA-SPION and unconjugated 
SPIONs. After 6 hours, the medium was removed and then 
the cells were washed with a PBS solution to remove free 
SPION. The labeled cells (FA-SPION and unconjugated 
SPION) were detached from the well using a trypsin/EDTA 
solution and harvested by centrifugation at 3000 rpm for 
5 minutes. The cells were resuspended in a PBS solution 
containing 1% paraformaldehyde followed by incubation at 
4°C for 2 hours. The cells were subsequently washed with 
PBS solution and again harvested at 3000 rpm for 3 min-
utes and finally counted with a hemocytometer. Thereafter, 
the cells were transferred in 1.5 mL of microcentrifuge 
tubes at fixed number (∼50,000 cells per tube) for each 
concentration of FA conjugated SPION and unconjugated   
SPION.
All the MRI experiments were performed using a Bruker-
Biospec 4.7 T MRI scanner (BrukerBioSpin Corporation, 
Billerica, MA) within a 72 mm transmit/receive coil with 
a homogeneous B1 field to obtain the MR images and the 
rest of the parameters used in the experiment were similar 
as used by Jain et al.31
Statistical analysis
Statistical analyses were performed using the Student’s 
t-test for unpaired data, and P values of 0.05 were consid-
ered   statistically significant. Data are presented as means ± 
standard error of the mean.
Results and discussion
Synthesis and characterization  
of hydrophobic SPIONs
Before one can utilize magnetic nanocrystals for biomedical 
applications, the utmost requirement is to develop well-
defined magnetic nanocrystals. The key requirement for this 
model system is the fabrication of high-quality magnetic 
nanocrystals in terms of the size, crystalline phase, and stoi-
chiometry, as these characteristics can affect the properties of 
SPIONs.13–15 In the present study, we synthesized magnetic 
nanocrystals through the thermal decomposition method 
in organic solvent to get high quality nanocrystals. TEM 
images demonstrated that the monodisperse SPIONs were 
formed in organic solvent (Figure 1A). The crystal struc-
ture information from an assembly of Fe3O4 nanoparticles 
was also obtained from both X-ray diffraction (XRD) and 
selected area electron diffraction (Figure 1B and C). The 
peaks were labeled with the indexed Bragg reflections of 
the magnetite structure and the particles were found to be 
highly   crystalline. Using the Debye–Scherrer formula, the 
average size of the crystallite was determined to be 10 nm, 
which was in good agreement with the average diameter 
of 8–10 nm measured from TEM images. These findings 
indicated that the particles were single crystalline.32 The 
selected area electron diffraction pattern taken from the area 
consisting of many particles represented Fe3O4 polycrystal-
line diffraction rings, in accordance with the XRD result. 
The magnetic properties of the SPIONs examined at room 
temperature by using a superconducting quantum interference 
device magnetometer indicated that the particles are super 
paramagnetic in nature. Furthermore, the net magnetization 
of the particle assemblies in the absence of an external field 
was zero. No hysteresis was seen when magnetization stud-
ies were performed on 10 nm Fe3O4 nanoparticles at room 
temperature (Figure 1D). Under a large external field, the 
magnetization of the particles aligned with the field direction 
and reached its saturation value (saturation magnetization, 
σs). Fourier-transform infrared (FTIR) spectra of SPION 
were recorded to confirm the presence of a coating layer 
consisting of oleic acid on the surface of the nanoparticles 
(data not shown). The FTIR spectrum of oleic acid showed 
strong characteristic peaks, assigned to the CH2 asymmetric 
and symmetric stretching at 2893 cm−1, 2841 cm−1, and scis-
soring at 1460 cm−1. A peak corresponding to the C=O asym-
metric stretching of ester of oleic acid around 1720 cm−1 was 
observed in iron oxide nanoparticles capped with oleic acid, 
which confirmed the capping of iron oxide nanoparticles by   
oleic acid.
Generation and characterization 
of SPIONs suitable for biomedical 
applications by ligand exchange
To make the SPION’s suitable for biomedical application, 
SPIONs are synthesized in aqueous media wherein nanopar-
ticles coated with hydrophilic dextran11 or polyvinyl alcohol.33 
But this process leads to large size and is limited in its ability 
to get uniform and monodispersed nanoparticles. SPIONs 
synthesized in organic solvent are highly hydrophobic and 
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Figure 1 Characterization of hydrophobic SPIONs. (A) TEM (B) XRD (C) SAED pattern (D) SQUID.
Abbreviations:  TEM,  transmission  electron  micrograph;  XRD,  X-ray  diffraction;  SAED,  single  area  electron  diffraction  pattern;  SQUID,  superconducting  quantum 
interference device.
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do not disperse well in water and thus cannot be used for bio-
logical application. Hydrophobic SPION’s were subjected to 
ligand exchanges to produce hydrophilic SPIONs. The ligand 
exchange process was carried out at different temperatures for 
different ligands with continuous stirring, wherein hydropho-
bic ligand was exchanged by hydrophilic ligand. We carried 
out ligand exchange reactions with four different ligands: 
TMAOH at 30°C, DMSA at 60°C, citric acid (CA, 90°C), 
and a combination of CA/2-Bromo2-methyl propionic acid 
(BMPA, 90°C). TMAOH functionalized SPIONs were found 
to be aggregated as shown in TEM images (Figure 2). For 
DMSA capped SPIONs dispersion was unstable over a period 
of time as evident from TEM images (Figure 2). Citric acid 
functionalized SPION (Figure 2) showed better dispersion 
stability but over a period of time it settled at the bottom 
due to aggregation. To enhance the dispersion stability, a 
combination of CA/BMPA was used. CA/BMPA capped 
SPIONs showed excellent dispersion stability as shown 
by TEM images (Figure 2D), which clearly indicated that 
there was no aggregation of nanoparticles upon transfer 
from organic to aqueous phase. CA/BMPA capped SPIONs 
were also characterized by XRD which clearly indicated 
that there was no alteration in crystal structure after ligand 
exchange. The FTIR spectra of CA and CA/BMPA showed 
complete ligand exchange while TMAOH and DMSA still 
had residual –CH2 peaks indicating incomplete removal of 
oleic acid from the surface of the SPIONs. This could be the 
possible cause of aggregation in these two systems. After 
ligand exchange, it was observed that CA/BMPA-SPIONs 
were more stable as compared to citric acid capped SPIONs 
(CA-SPIONs). CA/BMPA-SPIONs were stable up to 
250 mM NaCl solution and between pH 6 to 10. However, 
these SPIONs were aggregated below pH 6.0. Furthermore, 
CA-SPIONs were found to have stable dispersion in PBS 
(pH 7.4) up to 4–5 weeks while CA/BMPA-SPIONs were 
stable for 2 years as confirmed by TEM and dynamic light 
scattering (Figures 10A and B). CA/BMPA showed better 
dispersion stability of SPIONs for a longer period of time. 
Hence, all further studies were performed using CA/BMPA-
SPIONs unless otherwise stated. CA/BMPA-SPIONs were 
successfully conjugated to FA using EDC/NHS chemistry. 
Excess FA was removed by thoroughly washing the sample 
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Figure 3 Prussian blue histochemical reaction of MCF-7 and HepG2 cells following incubation with different concentrations (25–200 µg/mL) of FA-SPION and SPION. A(i–iv) 
MCF-7 with different concentrations of  FA-SPION B(i–iv) MCF-7 with different concentrations of unconjugated SPION. C(i–iv) HepG2 with different concentrations of 
FA-SPION D(i–iv) HepG2 with different concentrations of  unconjugated SPION. 
Abbrevations: MCF-7, hormone dependent breast carcinoma cells; HepG2, Hepato-carcinoma cells; FA-SPIONs, folic acid conjugated superparmagnetic iron oxide 
nanoparticles; SPION,  superparamagnetic iron oxide nanoparticles.
with PBS (pH 7.4).   Attenuated total reflectance-FTIR spec-
troscopy was performed to confirm the conjugation of FA 
with SPIONs. The results demonstrated additional peaks at 
1645 cm−1 and 1566 cm−1 in FA-conjugated SPIONs but the 
additional peaks were absent in unconjugated SPIONs, which 
indicate the –C=O stretch in FA-SPION due to –COOH 
group (data not shown). The smaller size of the ligands in 
our nanocrystals is extremely advantageous in physiological 
conditions. Retaining the small probe size has been shown to 
be critical for successful in vivo applications since   large-sized 
probes significantly reduce their bio-stability, diffusion, 
and circulation processes.14 Large size probes were shown 
to increase undesired nonspecific binding and reticuloen-
dothelial system uptake.34 Moreover, small sized probes 
can be potentially useful for enhanced biological targeting 
efficiency and specificity.35 Since the folate-receptor (FAR) is 
over expressed in multiple tumor types,22–24 specific targeting 
of the nanoparticles with FA would be potentially useful for 
biological functions.
Figure  2  TEM  micrograph  of  hydrophilic  SPION  coated  with  different  ligands   
(A) TMAOH (B) DMSA (C) CA (D) CA/BMPA.
Abbreviations: TEM, transmission electron microscopy; SPION, superparamagnetic 
iron  oxide  nanoparticles;  TMAOH,  tetramethyl  ammonium  hydroxide;  DMSA, 
dimercaptosuccinic acid; CA, citric acid; BMPA, 2-Bromo2-methyl propionic acid.
AB
CD
100 nm 20 nm
20 nm 20 nm
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3508
Kumar et alInternational Journal of Nanomedicine 2012:7
Uptake of FA-conjugated SPIONs  
in FAR overexpressing tumor cells
Prussian blue staining
Earlier studies have shown that FAR is overexpressed 
in multiple tumor types.22–24 We generated SPIONs that 
were conjugated with FA for tumor specific uptake and 
characterized them for appropriate biomedical applica-
tions. To demonstrate uptake of FA-conjugated SPIONs 
by FAR-positive tumor cells, further experiments were 
performed in hormone-dependent breast carcinoma 
cells, MCF-7 cells, and hepato-carcinoma cells HepG2. 
As a control, uptake of FA-conjugated SPIONs was also 
studied in FAR-negative cell lines, such as non-small cell 
lung carcinoma, A549. The results demonstrated that there 
was a clear increase of intracellular iron, as visualized by 
blue granules in Prussian blue staining of MCF-7 cells 
(Figures 3A and B). Similar results were obtained when the 
HepG2 cell line was used   (Figure 3C and D). Additionally, 
we also compared the uptake of FA-conjugated verses 
unconjugated SPIONs in MCF-7 and HepG2 cells. In this 
regard, by contrast to unconjugated SPIONs, the uptake of 
FA-conjugated SPIONs by MCF-7 and HepG2 cells was 
significantly increased (Figure 3A and D). Histological 
analysis of MCF-7 and HepG2 cells demonstrated sig-
nificant reduction in blue granules by cells treated with 
unconjugated SPIONs. While the increase in intracel-
lular unconjugated SPION granules was somewhat vis-
ible, however, the staining was considerably less intense 
as compared to that with the FA-conjugated SPIONs. 
Furthermore, substantially less staining was observed 
when FAR-negative A549 cells were treated with FA-
conjugated SPIONs (data not shown). Taken together, 
these findings indicated that conjugating the SPIONs 
with a tumor targeting agent, FA specifically, increased 
targeting and internalization of SPIONs in tumor   
cells.
Figure 4 TEM Studies of interaction of FA-SPION with MCF-7 cells. (I) (A) Attachment of FA-SPION on the cell membrane of MCF-7. (II) (A) Pit formation started (B) 
Clathrin Pit almost completed (C) multiple pits on the membrane (D) SPION inside the lysosome and start of coalescing of multiple vesicles. (III) (A) SPION in the pit (B) 
SPION inside the lysosome (C) Multi vesicular body  (MVB) filled with SPION (D) aggregated SPION inside the mature lysosomes. (IV) (a) SPIONs inside the different stages 
of lysosomes. (V) (a) Aggregation of SPION in lysosomes (b) SPION in the cytoplasm (outside lysosomes). (VI) (a) clathrin pit (b) ruptured MVB’s with SPIONS (possible 
entry of SPIONs to cytoplasm) (c) Multi Vesicular Body (MVB’s). 
Abbreviations:  MCF-7, hormone dependent breast carcinoma cells; FA-SPIONs, Folic acid conjugated superparamagnetic iron oxide nanoparticles; MVB’s, multi vesicular 
bodies; FA-SPIONs, folic acid conjugated superparmagnetic iron oxide nanoparticles; SPION, superparamagnetic iron oxide nanoparticles.
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TEM studies
FA-specific tumor targeting and internalization of FA- 
conjugated SPIONs was further confirmed using TEM 
analysis. Earlier studies have indicated that the uptake of 
nanoparticles is mediated via endocytosis.36 Endocytosis 
is considered to be the prime mechanism for the uptake 
of ,150 nm sized extracellular materials. Moreover, 
  clathrin coated pits, the prime plasma membrane compo-
nents, are shown to be involved in the uptake of a wide 
variety of molecules by receptor-mediated endocytosis.37,38 
To define internalization and cellular trafficking of SPIONs, 
MCF-7 cells were treated with FA-conjugated SPIONs 
and followed for different time intervals and analyzed by 
TEM. FA-conjugated SPIONs were initially seen on the 
MCF-7 cell membranes demonstrating interactions of 
FA with its receptors before internalization into the cells 
(Figure 4). At different time points, internalized FA-SPIONs 
were localized throughout the endocytic- degradative 
pathways (ie, endocytic vesicles, endosomal compartment, 
and lysosome).   Endosomes appeared as electron lucent 
multivescicular bodies with varying numbers of internal 
vesicles, probably representing the transition from early 
to late endosome   (Figure 4). We also observed numerous 
enlarged endosomes in which FA-conjugated SPIONs were 
accumulated.   Moreover,   FA-conjugated SPIONs were also 
seen in the cytosol. This study also indicated that other cel-
lular organelles did not show any structural abnormality by 
accumulation of SPIONs. Taken together, the results indi-
cated that the internalization of nanoparticles is dependent 
on the nature of the nanoparticle, incubation time, and the 
targeting molecule. These findings further indicate that the 
possible mechanism of uptake of FA-conjugated SPIONs, at 
least in part, is via receptor-mediated endocytosis. However, 
further in-depth studies are needed to clearly define the 
mechanism of internalization of FA-conjugated SPIONs 
in tumor cells.
Figure 5 Intracellular Fe concentration in MCF-7, HepG2 and A549. Iron concentration in MCF-7  (A), HepG2 (B) FAR positive and A549 (C) FAR negative cells that were 
treated with different concentrations ranging from 10 µg/mL–400 µg/mL of FA-SPION, SPION and competitive inhibition by FA (10 mM) of competitive FA-SPION for 6 hrs.
Abbreviations: FAR, folic acid receptor;FA, folic acid; MCF-7, hormone dependent breast carcinoma cells; HepG2, Hepato-carcinoma cells; A549, non-small cell lung 
carcinoma cells;FA-SPIONs, folic acid conjugated superparmagnetic iron oxide nanoparticles; SPION,  superparamagnetic iron oxide nanoparticles.
400 350 300 250 200
Fe conc (µg/mL)
F
e
 
c
o
n
c
 
(
p
g
/
c
e
l
l
)
150 100 50 0
0
20
40
60
80
100
120 FA-SPION
SPION
Competitive  FA-SPION
400 300 200
Fe conc (µg/mL)
F
e
 
c
o
n
c
 
(
p
g
/
c
e
l
l
)
100 0
0
50
100
FA-SPION
SPION
Competitive  FA-SPION
400 450 350 300 250 200
Fe conc (µg/mL)
F
e
 
c
o
n
c
 
(
p
g
/
c
e
l
l
)
150 100 50 −50 0
3
2
4
6
5
7
8
10
FA-SPION
SPION
11
9
AB
C
submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
3510
Kumar et alInternational Journal of Nanomedicine 2012:7
XTT assays
To assess any potential cytotoxicity of these FA-conjugated 
SPIONs on cells, further studies were performed using 
MCF-7 and HepG2 cells. These cell lines were treated with 
different concentrations of FA-SPIONs for 24 or 48 hours 
and analyzed by XTT assays for cell viability. The results 
demonstrated no toxicity of FA-conjugated SPIONs, even at 
the highest concentration tested (Figure 9A and B).
Concentration dependent cellular uptake studies
Earlier studies have shown that iron oxide nanoparticles 
biodegrade in lysosomes over a period of time.18 In this 
context, the FA-conjugated SPIONs described in the present 
study could be useful in multiple biomedical applications. 
To further define the practical implications of FA-conjugated 
SPION-cell interaction, we next studied the potency of cel-
lular uptake of these nanoparticles. The detailed cellular 
uptake studies were conducted as a function of concentra-
tion and time. These cellular iron quantification studies were 
performed using FAR-positive (MCF-7, HepG2) and  (A549) 
tumor cell lines. Investigations were also carried out to define 
the role of FA as a targeting agent and the surface coating effi-
cacy on internalization of SPIONs. The results demonstrated 
that the Fe content per cell, as determined by AAS, signifi-
cantly varied among different cell types (Figure 5). We found 
an accumulation of iron oxide in MCF-7 cells with the mean 
iron content ranges from 9.37 + 0.8 to 110 + 9.9 pg Fe/cell 
(Figure 5A). HepG2 cells also showed an intense uptake of 
FA-SPION, reaching an intracellular iron oxide concentration 
range of 18.18 + 1.6 to 98.48 + 6.81 pg Fe/cell (Figure 5B). 
Moreover, in concert with the results shown above, the uptake 
of FA-conjugated SPIONs is significantly higher than that 
of non-conjugated SPIONs. The accumulated iron oxide 
concentration range for MCF-7 and HepG2 cells treated with 
non-conjugated SPIONs was 0.83 + 0.9 to 62.5 + 6.9 pg Fe/
cell and 0.91 + 1.01 to 22.85 + 2.5 pg Fe/cell respectively. In 
comparison, MCF-7 and HepG2 cell uptake of FA-conjugated 
SPIONs was 2–15 times higher than that obtained with non-
conjugated SPIONs at different concentrations. To further 
define the targeting specificity of FA-SPIONs, uptake studies 
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Figure 6 Intracellular Fe concentration in different cell lines. Fe concentration in MCF-7 (A), HepG2 (B) FAR positive and A549 (C) FAR negative cells that were treated 
with 100 µg/mL concentration of FA-SPION, SPION and competitive inhibition by FA (10 mM) of competitive FA-SPION for different period of time ranging from 30 minutes 
to 12 hours.
Abbreviations: FAR, folic acid receptor; FA, folic acid; MCF-7, hormone dependent breast carcinoma cells; HepG2, Hepato-carcinoma cells; A549, non-small cell lung 
carcinoma cells; FA-SPIONs, folic acid conjugated superparmagnetic iron oxide nanoparticles; SPION, superparamagnetic iron oxide nanoparticles.
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Figure 7 Magnetic resonance imaging properties of FA-SPIONs: (A) signal intensity weighted images (TR 1/4 10,000 ms, TE 1/4 10 ms) of FA-SPIONs in phantom agar gel 
at various iron concentrations at 25°C, blank phantom agar gel was taken as a control (data as mean intensity within region of interest (ROI)); (B) T2-weighted MR images of 
FA-SPION in phantom gel with various concentrations at 4.7 T. (C) Graphs of R2 (R1 inset) against the iron concentration in FA-SPION.
Abbreviations: TR, repetition time; TE, echo time; T2, transverse relaxation time; R2, transverse relaxation rate; R1, longitudinal relaxation rate; ROI, region of interest; 
FA-SPIONs, folic acid conjugated superparmagnetic iron oxide nanoparticles.
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Figure 8 Magnetic resonance imaging properties of MCF-7 cells labeled with SPIONs: (A) signal intensity weighted images (TR 1/4 10,000 ms, TE 1/4 10 ms) of MCF-7 cells 
labeled FA-SPIONs and SPIONs in DMEM media at various iron concentrations at 25°C, blank phantom agar gel was taken as a control (data as mean intensity within region 
of interest (ROI)); (B) T2-weighted MR images of MCF-7 cancer cells treated with different concentrations FA-SPION and SPION (C) Graph of R2 of MCF-7 cancer cells 
treated with different concentrations FA-SPION and SPION.
Abbreviations: TR, repetition time; TE,echo time; T2, transverse relaxaxtion time; R2, transverse relaxation rate; ROI, region of interest; MCF-7, hormone-dependent 
breast carcinoma cells; FA-SPIONs, folic acid conjugated superparmagnetic iron oxide nanoparticles; SPION, superparamagnetic iron oxide nanoparticles. 
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of FA-SPIONs were compared between FAR-positive and 
FAR-negative tumor cell lines. The results demonstrated that 
uptake of FA-SPIONs by HepG2 or MCF-7 cells was 10–12 
times more than that compared with A549 (Figure 5C). The 
increased uptake by A549 cells at higher concentrations 
of nanoparticles is likely due to increased availability of 
the nanoparticles and internalization through nonspecific 
mechanisms. In this regard, the results from our   present 
study are in agreement with the previously published   findings 
regarding the uptake of non-conjugated SPIONs at very high 
concentrations.39–42
To further assess the competitive and specific uptake of 
FA-conjugated CA/BMPA-SPIONs, we treated MCF-7 or 
HepG2 cells with FA-SPIONs in the presence or absence 
of free FA in molar excess. The results demonstrate that 
the uptake of FA-SPIONs by MCF-7 cells was signifi-
cantly decreased when the cells were grown in the pres-
ence of an excess amount of free FA (Figure 5A). Similar 
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Figure 9 Cytotoxicity (XTT assay) to cells exposed to different concentrations (62.5–1000 µg/mL) of FA-SPION and SPION for different time points 24 and 48 hours.   
(A) MCF-7 cells; (B) HepG2 cells.
Abbreviations:  XTT,  (2,3-Bis-(2-Methoxy-4-Nitro-5-Sulfophenyl)-2H-Tetrazolium-5-Carboxanilide);  FA-SPION,  folic  acid  conjugated  superparamagnetic  iron  oxide 
nanoparticles; SPION, superparamagnetic iron oxide nanoparticles; MCF-7, hormone dependent breast carcinoma cells; HepG2, Hepato-carcinoma cells.
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results were obtained in HepG2 cells (Figure 5B). These 
findings strongly demonstrated that free FA competed 
with the FA-SPIONs for uptake by the cells and thereby 
confirmed that FA-SPIONs were specifically targeted at 
folate receptors.
Time dependent cellular uptake studies
Additional studies were carried out to determine the internal-
ization kinetics of FA-conjugated and non-conjugated SPI-
ONs into MCF-7 and HepG2 cells at different time intervals. 
In these studies, MCF-7 cells were treated with 100 µg of FA-
conjugated or non-  conjugated SPIONs and internalization 
kinetics were studied over a period of time. Figure 6A shows 
the internalization kinetics of conjugated and unconjugated 
SPIONs in MCF-7 cells. The results convincingly indicated 
that the uptake of FA-conjugated SPIONs was much higher 
compared to non-conjugated SPIONs (Figure 6A). However, 
internalization of FA-conjugated SPIONs over a period of 
time was not uniform. A unique pattern was observed in the 
uptake of FA-conjugated SPIONs by MCF-7 cells. Initially 
there was an increase in SPIONs concentration (134 + 12.14 
pg Fe/cell) followed by a decline at 2 to 4 hours (∼10–20 pg 
Fe/cell) and then again a sharp increase to 92.67 + 8.34 pg Fe/
cell by 6 hours which was maintained through long intervals 
(Figure 6A). Similarly, HepG2 cells have also shown higher 
uptake at 30 minutes followed by a small decline at 2 hours 
and finally reached to a concentration of 75.75 + 9.17 pg Fe/
cell (Figure 6B). In comparison to unconjugated SPIONs, 
the FA-conjugated SPIONs showed a prolonged retention 
of internalized nanoparticles, which may be helpful for MRI 
detection of FA receptor expressing cells. The initial decline 
in the uptake of FA-conjugated SPIONs observed in this 
study may in part be explained by the probable phenomenon 
of exocytosis. Nanoparticle endocytosis and exocytosis are 
dynamic and energy-dependent processes, which are pro-
ceeding simultaneously in eukaryotic cells.43–45
MRI characteristics of magnetic nanoparticles  
in phantom agar gel and MCF-7 cells
The T1 and T2-weighted MRI of FA-SPIONs in water was 
examined at 4.7T using various concentrations in phantom gel 
and MCF-7 cells. The results demonstrated that as the SPION 
concentration was increased, the signal intensity of spin–spin 
relaxation time T2-weighted MRI image decreased. The T2 
and T1 relaxivity coefficient (R2 and Rl values), which are the 
measures of the spin–spin relaxation rate (T2
−1) and spin lattice 
relaxation rate (T1
−1) per unit Fe concentration, were calcu-
lated at 4.7T to be 222 L mmol−1 sec−1 and 4.11 L mmol−1 sec−l, 
respectively (Figure 7C (R1 Inset graph)). For the commercial 
products, Feridex and Resovist, the R2values were 105 L 
mmol−1 sec−1 and 176 L mmol−1 sec−1, respectively, and the R1 
values were 2.3 L mmol−1 sec−1 and 2.8 L mmol−1 sec−1, respec-
tively, at 4.7T.46 Therefore, the R2 of FA-SPIONs was higher 
and the R1 of FA-SPIONs was almost equivalent to those of 
commercial products,   respectively. It is well known that the 
relaxivity ratio, R2/R1, is usually an important parameter to 
estimate the efficiency of negative contrast agents. In our work 
R2/R1 was calculated to be 54, which was higher than Feridex 
and a little less than Resovist coated with higher molecular 
weight ligands. Figure 8B shows T2-weighted MR images in 
untreated MCF-7 cells or treated with FA-conjugated-SPION 
at three different Fe concentrations. Results were also com-
pared to that with MCF-7 cells treated with unconjugated 
SPIONs. The results demonstrate that T2-weighted MR images 
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of FA-SPION treated MCF-7 cells were darker than those 
of either the unconjugated SPION or the untreated control 
at all the Fe concentrations used in this study   (Figure 8B). 
T2 relaxation time of the FA-SPION- treated cells decreased 
from 777.78 to 163.66 ms−1 in comparison to non-conjugated 
SPION which showed a decrease from 1015.13 to 493 ms−1 
at Fe concentrations ranging from 40 µg Fe/mL to 160 µg 
Fe/mL. The R2 value of cells treated with FA-SPION was 
higher as compared to nonconjugated SPIONs (Figure 8C). 
As expected, the FA conjugated SPIONs offered a specific 
targeting ability in MCF-7 cells that overexpress FAR.
Conclusion
FA conjugated, CA/BMPA capped iron oxide nanoparticles 
were synthesized and characterized for MR imaging of breast 
cancer MCF-7 cells. The hydrophilic SPIONs capped with 
CA/BMPA and conjugated with FA were found to be mono-
dispersed, highly stable in PBS and have shown dispersion 
stability for more than 2 years as observed from dynamic light 
scattering and TEM studies. FA-SPIONs showed no cellular 
cytotoxicity and were expected to be completely degraded 
by enzymes present in physiological conditions. The cellular 
uptake of FA-SPIONs was mediated through FAR mediated 
endocytosis and a possible mechanism, at least in part, is a 
clathrin mediated pathway. As verified by Prussian blue stain-
ing, iron content and in vitro MR imaging, FA-SPIONs had 
better targeting tropism, showed better cellular internalization 
in FAR-positive MCF-7 and HepG2 cells and maintained 
for longer periods in these cells than did their non-targeted 
counterparts. The relaxivity of FA-SPIONs was much greater 
than that of the existing commercial products. T2-weighted 
images of MCF-7 breast cancer cells that overexpressed 
FAR showed significantly enhanced signal intensities. The 
high intracellular uptake of FA-conjugated SPIONs may 
help to detect the collection of a small number of cancer 
cells (early and mirometastasis) which is difficult to detect by 
conventional MRI imaging. Furthermore the excellent long 
term colloidal stability may enhance its translational   potential. 
Therefore, the FA-SPIONs, possessing good colloidal stability 
and affording excellent sensitivity of imaging, are proposed as 
a potential MRI contrast agent for the   detection of breast cancer 
and other cancer cells overexpressing the folate receptor.
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